António Almeida Lab

Epigenetic oncogenesis lab
António de Almeida

António de Almeida | Dean of Católica Medical School

With its main focus on unravelling the oncogenic processes in myeloproliferative neoplasms (MPN), our lab focuses on transcriptional regulation of gene expression by epigenetic mechanisms: the involvement of chromatin remodeling and transcription factors.

Despite the deep understanding of the role that driver mutations have in the oncopathogenesis of MPN, there are still many aspects of these diseases, such as clinical heterogeneity and differing rates of progression, which remain to be explained.

Our lab focuses on the role of epigenetic mechanisms in these neoplasms and how they can be manipulated to identify novel treatment strategies.

Selected references

  1. Hélio Belo, Gabriela Silva, Bruno A Cardoso, Beatriz Porto, Jordi Minguillon, José Barbot, Jorge Coutinho, José A. Casado, Manuela Benedito, Hema Saturnino, Emília Costa, Juan A. Bueren, Jordi Surralles, Antonio Almeida. Epigenetic alterations in Fanconi anaemia: Role in pathophysiology and therapeutic potential. PLoS ONE 2015 Oct
  2. Cardoso BA, Belo H, Barata JT, Almeida AM.The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways. PLoS One. 2015 Dec 1;10(12)
  3. Raquel Alves, Ana Cristina Gonçalves, Sergio Rutella, Antonio Almeida, Ana Bela Sarmento-Ribeiro.Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance. September 2021. Cancers 13(19):4820 DOI: 10.3390/cancers13194820.